Procalcitonin levels in septic and nonseptic subjects with AKI and ESKD prior to and during continuous kidney replacement therapy (CKRT)

Background Procalcitonin is a 14.5 kDa protein used clinically as a marker of sepsis and therapeutic response to antibiotic therapy. However, its utility in critically ill patients with either acute kidney injury (AKI) or end-stage kidney disease (ESKD) who require continuous kidney replacement ther...

Full description

Saved in:

Bibliographic Details
Published in:	Critical care (London, England) Vol. 29; no. 1; p. 171
Main Authors:	Foulon, North, Haeger, Sarah M., Okamura, Kayo, He, Zhibin, Park, Bryan D., Budnick, Isadore M., Madison, David, Kennis, Matthew, Blaine, Rachel, Miyazaki, Makoto, Jalal, Diana I., Griffin, Benjamin R., Aftab, Muhammad, Colbert, James F., Faubel, Sarah
Format:	Journal Article
Language:	English
Published:	London BioMed Central 30.04.2025 BioMed Central Ltd Springer Nature B.V
Subjects:	Acute Kidney Injury - blood Acute Kidney Injury - therapy Aged Analysis Antibiotics Bacterial infections Biomarkers - analysis Biomarkers - blood Blood proteins Care and treatment Chronic kidney failure Cohort Studies Complications and side effects Continuous Renal Replacement Therapy - methods Creatinine Critical Care Medicine Critically ill Diagnosis Electronic health records Emergency Medicine Female Health aspects Hemodialysis Hemodynamics Humans Infection Intensive Kidney diseases Kidney Failure, Chronic - blood Kidney Failure, Chronic - therapy Male Medicine Medicine & Public Health Middle Aged Performance evaluation Plasma Population Procalcitonin - analysis Procalcitonin - blood Renal replacement therapy Retrospective Studies Risk factors Sepsis Sepsis - blood Sepsis - diagnosis United States Sepsis CKRT Procalcitonin ESKD AKI
ISSN:	1364-8535, 1466-609X, 1364-8535, 1466-609X, 1366-609X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!